Founded in 1988, Ampersand is a middle-market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. 

Venture Capital

Ampersand Capital Partners

Herb H. Hooper

Albert Chiu

Arya Mehrabanzad

Mario J. Reto

Greg W. Magoon

Jay S. Ray

Hidde Van Kerckhoven

Sven M. Henrichwark

Dean D. Schauer

Laurence R. McCarthy

David Q. Anderson

Melanie M. Fan

Patrick D. Walsh

Trevor L. Wahlbrink

David B. Patteson

Paul H. Johnson

David J. Parker

Benoit P. Bouche

Eric B. Lev

Frank R. Witney

Richard A. Charpie

Marina Pellón-Consunji

Geoffrey P. Teillon

Julie F. Giles

Dana L. Niles

Ampersand Capital Partners has a board of directors with experience in a variety of industries and fields. AvCarb Material Solutions and EAA are just two examples of the companies represented on the board. With members who have studied engineering at Columbia University in the City of New York, the board is able to provide a wealth of knowledge and experience to the company.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Ampersand Capital Partners

Leadership Team

CEO and Executive Team